SpectraCure AB (OSTO:SPEC) Cyclically Adjusted FCF per Share: kr-0.18 (As of Mar. 2026)


What is SpectraCure AB Cyclically Adjusted FCF per Share?

SpectraCure AB OSTO:SPEC -9.06% Cyclically Adjusted FCF per Share is kr-0.18 as of Mar. 2026. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

SpectraCure AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-0.018. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.18 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-07), SpectraCure AB's current stock price is kr0.0582. SpectraCure AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr-0.18. SpectraCure AB's Cyclically Adjusted Price-to-FCF of today is .


SpectraCure AB  (OSTO:SPEC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


SpectraCure AB Cyclically Adjusted FCF per Share Related Terms


SpectraCure AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Cyclically Adjusted FCF per Share Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.17 -0.19

SpectraCure AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.19 -0.19 -0.19 -0.18

OSTO:SPEC vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, SpectraCure AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SpectraCure AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's Cyclically Adjusted Price-to-FCF falls into.



SpectraCure AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SpectraCure AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.018/133.5600*133.5600
=-0.018

Current CPI (Mar. 2026) = 133.5600.

SpectraCure AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.039 101.019 -0.052
201609 -0.022 101.138 -0.029
201612 -0.210 102.022 -0.275
201703 0.080 102.022 0.105
201706 -0.021 102.752 -0.027
201709 -0.016 103.279 -0.021
201712 -0.029 103.793 -0.037
201803 -0.002 103.962 -0.003
201806 -0.040 104.875 -0.051
201809 -0.030 105.679 -0.038
201812 -0.038 105.912 -0.048
201903 -0.015 105.886 -0.019
201906 -0.096 106.742 -0.120
201909 -0.031 107.214 -0.039
201912 -0.046 107.766 -0.057
202003 -0.015 106.563 -0.019
202006 -0.041 107.498 -0.051
202009 -0.026 107.635 -0.032
202012 -0.006 108.296 -0.007
202103 -0.017 108.360 -0.021
202106 -0.053 108.928 -0.065
202109 -0.019 110.338 -0.023
202112 -0.028 112.486 -0.033
202203 -0.032 114.825 -0.037
202206 -0.047 118.384 -0.053
202209 -0.033 122.296 -0.036
202212 -0.032 126.365 -0.034
202303 -0.048 127.042 -0.050
202306 -0.049 129.407 -0.051
202309 -0.028 130.224 -0.029
202312 -0.027 131.912 -0.027
202403 -0.088 132.205 -0.089
202406 -0.050 132.716 -0.050
202409 -0.050 132.304 -0.050
202412 -0.028 132.987 -0.028
202503 -0.233 132.825 -0.234
202506 -0.003 133.699 -0.003
202509 -0.054 133.480 -0.054
202512 -0.028 133.390 -0.028
202603 -0.018 133.560 -0.018

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-0.18 mean?
SpectraCure AB (OSTO:SPEC) has a Cyclically Adjusted FCF per Share of kr-0.18 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on SpectraCure AB and its competitors.
Is SpectraCure AB's Cyclically Adjusted FCF per Share too high?
SpectraCure AB's current Cyclically Adjusted FCF per Share is kr-0.18.
How does SpectraCure AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
SpectraCure AB's Cyclically Adjusted FCF per Share of kr-0.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Cyclically Adjusted FCF per Share is kr-0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Cyclically Adjusted FCF per Share of kr-0.18. The current Cyclically Adjusted FCF per Share is kr-0.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Cyclically Adjusted FCF per Share is kr-0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.